Literature DB >> 11421612

Intestinal and hemodynamic impairment following mesenteric ischemia/reperfusion.

A Khanna1, J E Rossman, H L Fung, M G Caty.   

Abstract

BACKGROUND: Clinical intestinal ischemia/reperfusion (I/R) injury results in local and systemic dysfunction. A rat model of transient mesenteric occlusion has been used to study this phenomenon. However, a systematic analysis of the rat model with respect to intestinal permeability and hemodynamics has not been carried out.
MATERIALS AND METHODS: In anesthetized rats, the superior mesenteric artery was occluded for 60 min, followed by reperfusion for 4 h. Intestinal impairment was evaluated via histological examination and by measuring ex vivo apparent permeability coefficients (Papp) of mannitol (0.18 kDa), inulin (5 kDa), and dextran (70 kDa). Hemodynamic effects of intestinal I/R were determined by monitoring mean arterial pressure (MAP) and heart rate (HR) via a catheter placed in the femoral artery.
RESULTS: The animal model was associated with increased ex vivo Papp for mannitol and inulin. Although I/R injury was accompanied by significant histological disruption, there was no observable alteration in dextran permeability, suggesting that the loss in normal barrier function was limited to low-molecular-weight compounds. Hemodynamic measurements indicated that reperfusion induced a precipitous and sustained fall in MAP. HR values fell sharply following reperfusion but gradually increased and eventually "overshot" to values greater than baseline.
CONCLUSIONS: Our findings demonstrate the selective loss of barrier function of the small bowel following intestinal I/R. Furthermore, these results also illustrate the importance of selecting appropriate permeability markers for the evaluation of intestinal damage. In light of the significant hemodynamic disruption accompanying the animal model, our investigation also points toward the need for developing therapeutic strategies that mitigate the local and systemic effects of intestinal I/R injury. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11421612     DOI: 10.1006/jsre.2001.6103

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  22 in total

1.  Circulating endotoxemia: a novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease.

Authors:  Christopher W McIntyre; Laura E A Harrison; M Tarek Eldehni; Helen J Jefferies; Cheuk-Chun Szeto; Stephen G John; Mhairi K Sigrist; James O Burton; Daljit Hothi; Shvan Korsheed; Paul J Owen; Ka-Bik Lai; Philip K T Li
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

Review 2.  Hepatosplanchnic circulation in cirrhosis and sepsis.

Authors:  Meghan Prin; Jan Bakker; Gebhard Wagener
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

3.  Nonmuscle myosin II regulates migration but not contraction in rat hepatic stellate cells.

Authors:  Cathy C Moore; Ashley M Lakner; Christopher M Yengo; Laura W Schrum
Journal:  World J Hepatol       Date:  2011-07-27

4.  The impact of antihypertensive drug therapy on endotoxemia in elderly patients with chronic kidney disease.

Authors:  Stephen G John; Paul J Owen; Laura E A Harrison; Cheuk-Chun Szeto; Ka-Bik Lai; Philip K T Li; Christopher W McIntyre
Journal:  Clin J Am Soc Nephrol       Date:  2011-08-18       Impact factor: 8.237

5.  Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury.

Authors:  Dorothy V Rocourt; Veela B Mehta; Gail E Besner
Journal:  J Surg Res       Date:  2007-02-07       Impact factor: 2.192

6.  Abdominal compartment syndrome in patients with severe acute pancreatitis in early stage.

Authors:  Hong Chen; Fei Li; Jia-Bang Sun; Jian-Guo Jia
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

7.  Comparative protection against rat intestinal reperfusion injury by a new inhibitor of sPLA2, COX-1 and COX-2 selective inhibitors, and an LTC4 receptor antagonist.

Authors:  Thiruma V Arumugam; Naomi Arnold; Lavinia M Proctor; Michelle Newman; Robert C Reid; Karl A Hansford; David P Fairlie; Ian A Shiels; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2003-07-29       Impact factor: 8.739

8.  Ukrain (NSC 631570) ameliorates intestinal ischemia-reperfusion-induced acute lung injury by reducing oxidative stress.

Authors:  Cengiz Kocak; Fatma Emel Kocak; Raziye Akcilar; Aydin Akcilar; Bircan Savran; Sezgin Zeren; Zulfu Bayhan; Zeynep Bayat
Journal:  Bosn J Basic Med Sci       Date:  2016-01-15       Impact factor: 3.363

9.  Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.

Authors:  Lavinia M Proctor; Thiruma V Arumugam; Ian Shiels; Robert C Reid; David P Fairlie; Stephen M Taylor
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

10.  Exploring the Link Between Hepatic Perfusion and Endotoxemia in Hemodialysis.

Authors:  Raanan Marants; Elena Qirjazi; Ka-Bik Lai; Cheuk-Chun Szeto; Philip K T Li; Fiona Li; Ting-Yim Lee; Christopher W McIntyre
Journal:  Kidney Int Rep       Date:  2021-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.